UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
{
"resourceType" : "RegulatedAuthorization",
"id" : "Nobligan50mgkapselhard-SE-PLC-RA",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization Nobligan50mgkapselhard-SE-PLC-RA</b></p><a name=\"Nobligan50mgkapselhard-SE-PLC-RA\"> </a><a name=\"hcNobligan50mgkapselhard-SE-PLC-RA\"> </a><a name=\"hcNobligan50mgkapselhard-SE-PLC-RA-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/12845</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-Nobligan50mgkapselhard-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000515-00012845,http://ema.europa.eu/fhir/eurdId#3002; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Capsule, hard; indication = Behandling av måttlig till svår smärta.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = tramadol</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}\">Valid</span></p><p><b>statusDate</b>: 1995-09-15</p><p><b>holder</b>: <a href=\"Organization-LOC-100006949.html\">Organization Grünenthal GmbH</a></p><h3>Cases</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}\">First Authorisation</span></td><td>1995-09-15</td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
"value" : "12845"
}
],
"subject" : [
{
🔗 "reference" : "MedicinalProductDefinition/Nobligan50mgkapselhard-SE-PLC-MPD"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/220000000060",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"region" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
}
],
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072049",
"code" : "100000072099",
"display" : "Valid"
}
]
},
"statusDate" : "1995-09-15",
"holder" : {
🔗 "reference" : "Organization/LOC-100006949"
},
"case" : {
"type" : {
"coding" : [
{
"system" : "https://ema.europa.eu/fhir/authorisationDateType",
"code" : "dateOfFirstAuthorisation",
"display" : "First Authorisation"
}
]
},
"dateDateTime" : "1995-09-15"
}
}